These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17218088)

  • 1. [End of life and clinical research in pediatric oncology].
    Davous D; Doz F; Heard M;
    Arch Pediatr; 2007 Mar; 14(3):274-8. PubMed ID: 17218088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk announcement in paediatric cancerology: strengthen the therapeutic alliance].
    Doz F; Davous D; Seigneur E; Heard M;
    Arch Pediatr; 2008 Mar; 15(3):291-300. PubMed ID: 18321689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer.
    Hechler T; Blankenburg M; Friedrichsdorf SJ; Garske D; Hübner B; Menke A; Wamsler C; Wolfe J; Zernikow B
    Klin Padiatr; 2008; 220(3):166-74. PubMed ID: 18478489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I research and the meaning of direct benefit.
    Ross L
    J Pediatr; 2006 Jul; 149(1 Suppl):S20-4. PubMed ID: 16829237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the development of ethical practices in paediatric clinical trials: the special position of the terminally ill child.
    Keough WJ
    J Law Med; 2006 Feb; 13(3):370-86. PubMed ID: 16506728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?
    Miller FG; Joffe S
    Clin Trials; 2008; 5(6):617-23. PubMed ID: 19029210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical considerations in pediatric oncology phase I clinical trials according to The Belmont Report.
    Haylett WJ
    J Pediatr Oncol Nurs; 2009; 26(2):107-12. PubMed ID: 19190176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Until the last breath: exploring the concept of hope for parents and health care professionals during a child's serious illness.
    Reder EA; Serwint JR
    Arch Pediatr Adolesc Med; 2009 Jul; 163(7):653-7. PubMed ID: 19581549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and design issues of phase I clinical trials in cancer patients.
    Grünwald HW
    Cancer Invest; 2007 Mar; 25(2):124-6. PubMed ID: 17453824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive survey about causes of illness given by the parents of children with cancer.
    Matteo B; Pierluigi B
    Eur J Oncol Nurs; 2008 Apr; 12(2):134-41. PubMed ID: 18069066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory clinical trials: implementation modes & guidelines, scope and regulatory framework.
    Francillon A; Pickering G; Belorgey C
    Therapie; 2009; 64(3):149-59. PubMed ID: 19671427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of joint evaluation of efficacy and toxicity in phase II clinical trials.
    Tournoux C; De Rycke Y; Médioni J; Asselain B
    Contemp Clin Trials; 2007 Jul; 28(4):514-24. PubMed ID: 17331808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring parents' environmental needs at the time of a child's death in the pediatric intensive care unit.
    Meert KL; Briller SH; Schim SM; Thurston CS
    Pediatr Crit Care Med; 2008 Nov; 9(6):623-8. PubMed ID: 18838930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.